ORBIMED ADVISORS LLC purchased 41.6% of their position (444.44K shares) of ARRIVENT BIOPHARMA, INC. on the open market

Open‑market purchase worth $8.00M — a major conviction buy. The strongest form of insider conviction signal.

P · 2 purchases

ORBIMED ADVISORS LLC

Filed: 1/31/2024ACC: 0001104659-24-008799

InsiderORBIMED ADVISORS LLCCIK 1055951

→

IssuerARRIVENT BIOPHARMA, INC.CIK 1868279

Director10% Owner

Since Jan 2024

+444.44K

Net shares

Net buyer

$8.00M

Total acquired

Open market trades

2B · 0S

Total transactions

3.03M acquired · 2.58M disposed

Non-Derivative Transactions6

Common Stock

Indirect

C · Conversion

+821.83K

Price / share

—

Trade value

—

% of position

New position

1/30/2024

0.00→821.83K

Common Stock

Indirect

C · Conversion

+821.83K

Price / share

—

Trade value

—

% of position

New position

1/30/2024

0.00→821.83K

Common Stock

Indirect

C · Conversion

+469.62K

Price / share

—

Trade value

—

% of position

57.1%

1/30/2024

821.83K→1.29M

Common Stock

Indirect

C · Conversion

+469.62K

Price / share

—

Trade value

—

% of position

57.1%

1/30/2024

821.83K→1.29M

Common Stock

Indirect

P · Purchase

+222.22K

Price / share

$18.00

Trade value

$4M

% of position

17.2%

1/30/2024

1.29M→1.51M

Common Stock

Indirect

P · Purchase

+222.22K

Price / share

$18.00

Trade value

$4M

% of position

17.2%

1/30/2024

1.29M→1.51M

Total

Net shares

+3.03M

Net value

$8M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Indirect	1/30/2024	C · Conversion	+821.83K	—	—	New position	0.00	821.83K
Common Stock Indirect	1/30/2024	C · Conversion	+821.83K	—	—	New position	0.00	821.83K
Common Stock Indirect	1/30/2024	C · Conversion	+469.62K	—	—	57.1%	821.83K	1.29M
Common Stock Indirect	1/30/2024	C · Conversion	+469.62K	—	—	57.1%	821.83K	1.29M
Common Stock Indirect	1/30/2024	P · Purchase	+222.22K	$18.00	$4M	17.2%	1.29M	1.51M
Common Stock Indirect	1/30/2024	P · Purchase	+222.22K	$18.00	$4M	17.2%	1.29M	1.51M
Total			+3.03M		$8M

Derivative Transactions4

Series A Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

821.83K shares

−821.83K

Strike price

Held after

0.00

Exercisable

—

1/30/2024

Series A Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

821.83K shares

−821.83K

Strike price

Held after

0.00

Exercisable

—

1/30/2024

Series B Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

469.62K shares

−469.62K

Strike price

Held after

0.00

Exercisable

—

1/30/2024

Series B Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

469.62K shares

−469.62K

Strike price

Held after

0.00

Exercisable

—

1/30/2024

Security	Converts To	Date	Type	Shares	Exercisable
Series A Preferred Stock Indirect	Common Stock821.83K shares	1/30/2024	C · Conversion	−821.83K	—
Series A Preferred Stock Indirect	Common Stock821.83K shares	1/30/2024	C · Conversion	−821.83K	—
Series B Preferred Stock Indirect	Common Stock469.62K shares	1/30/2024	C · Conversion	−469.62K	—
Series B Preferred Stock Indirect	Common Stock469.62K shares	1/30/2024	C · Conversion	−469.62K	—